FB
Francois Brisebois Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Savara
SVRA
$643M
| $3.72 | $6 |
61%
upside
| Outperform | 22 days ago |
|
2
Abeona Therapeutics
ABEO
$353M
| $6.89 | $16 |
132%
upside
| Outperform | 6 months ago |
|
3
Tarsus Pharmaceuticals
TARS
$2.43B
| $57.63 | $72 |
25%
upside
| Outperform | 7 months ago |
|
4
Harmony Biosciences
HRMY
$2.07B
| $35.99 | $61 |
69%
upside
| Outperform | 7 months ago |
|
5
MindMed
MNMD
$702M
| $9.22 | $20 |
117%
upside
| Outperform | 8 months ago |
|
|
AVDL
6
Avadel Pharmaceuticals
AVDL
$1.53B
| $15.76 | $30 |
90%
upside
| Outperform | 10 months ago |
|
7
Praxis Precision Medicines
PRAX
$986M
| $46.85 | $163 |
248%
upside
| Outperform | 10 months ago |
|
8
Dyne Therapeutics
DYN
$2.02B
| $14.22 | $55 |
287%
upside
| Outperform | 1 year ago |
|
9
DiaMedica Therapeutics
DMAC
$317M
| $6.14 | $6 |
2%
downside
| Outperform | 1 year ago |
|
|
CNTA
10
Centessa Pharmaceuticals
CNTA
$2.11B
| $15.73 | $14 |
11%
downside
| Outperform | 1 year ago |
|
11
Aquestive Therapeutics
AQST
$656M
| $5.42 | $15 |
177%
upside
| Outperform | 1 year ago |
|
12
Simulations Plus
SLP
$279M
| $13.84 | $65 |
370%
upside
| Outperform | 1 year ago |
|
13
Aldeyra Therapeutics
ALDX
$334M
| $5.56 | $10 |
80%
upside
| Outperform | 1 year ago |
|
|
CMPS
14
Compass Pathways
CMPS
$493M
| $5.14 | $50 |
873%
upside
| Outperform | 3 years ago |
|
|
AVDL
15
Avadel Pharmaceuticals
AVDL
$1.53B
| $15.76 | $15 |
5%
downside
| Buy | 5 years ago |
|